By attending the 2nd Annual Global Vaccine Forum you will find the answers on the most challenging questions that will be shaping the vaccine’s market in upcoming years.
Benefit from understanding:
Which developing world needs have stayed still unmet?
Development of influenza vaccines – What are the main technical and regulatory aspects to consider?
How to acquire best collaboration practices?
How much to invest in biodefense?
Which are the crucial knowledge when it comes to combination vaccines?
Is there a way how to overcome market access barriers?
What is the position of HPV vaccines and allergy vaccines on the market in 2012?
What are the critical issues in the cancer vaccine development?
This is just a short list of questions to be answered by 20+ opinion leaders from Sanofi Pasteur, European Vaccine Initiative, Health Protection Agency, Merck & Co., Serum Institute of India, Novartis Vaccines & Diagnostics and others.
This year’s special features:
Pre-conference workshop focused on the recent concerns in the immunization against seasonal and pandemic influenza virus and development of combined norovirus-rotavirus vaccine
Vaccine lifecycle – closer look at the different stages
Special insight into the recent developments in cancer vaccines from GSK, Takeda and Genticel perspective